Cargando…

CD8+ T Cells Protect During Vein Graft Disease Development

Aims: Vein grafts are frequently used conduits for arterial reconstruction in patients with cardiovascular disease. Unfortunately, vein graft disease (VGD) causes diminished patency rates. Innate immune system components are known to contribute to VGD. However, the role of T cells has yet to be esta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simons, Karin H., de Vries, Margreet R., Peters, Hendrika A. B., Jukema, J. Wouter, Quax, Paul H. A., Arens, Ramon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584838/ https://www.ncbi.nlm.nih.gov/pubmed/31263704 http://dx.doi.org/10.3389/fcvm.2019.00077

Ejemplares similares

Interfering in the ALK1 Pathway Results in Macrophage-Driven Outward Remodeling of Murine Vein Grafts
por: de Jong, Alwin, et al.
Publicado: (2022)

Inflammation in Vein Graft Disease
por: de Vries, Margreet R., et al.
Publicado: (2018)

P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3(*)Leiden Mice via Systemic Inhibition of Regulatory T Cells
por: de Jong, Alwin, et al.
Publicado: (2021)

The Role of Immunomodulation in Vein Graft Remodeling and Failure
por: Baganha, Fabiana, et al.
Publicado: (2020)

bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice
por: Parma, Laura, et al.
Publicado: (2020)

miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature
por: Goossens, Eveline A. C., et al.
Publicado: (2019)

Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts
por: Baganha, Fabiana, et al.
Publicado: (2022)

IRF3 and IRF7 mediate neovascularization via inflammatory cytokines
por: Simons, Karin H., et al.
Publicado: (2019)

The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease
por: Bezhaeva, Taisiya, et al.
Publicado: (2022)

Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice
por: Parma, Laura, et al.
Publicado: (2020)

Editorial: Inflammation and immunomodulation in cardiovascular remodeling
por: Ewing, Mark, et al.
Publicado: (2022)

Plaque Rupture Complications in Murine Atherosclerotic Vein Grafts Can Be Prevented by TIMP-1 Overexpression
por: de Vries, Margreet R., et al.
Publicado: (2012)

Mechanotransduction in Coronary Vein Graft Disease
por: Ruiter, Matthijs Steven, et al.
Publicado: (2018)

Assessment of Microvessel Permeability in Murine Atherosclerotic Vein Grafts Using Two-Photon Intravital Microscopy
por: Baganha, Fabiana, et al.
Publicado: (2020)

Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices: A Systematic Review and Meta-Analysis
por: Yu, Jianhong, et al.
Publicado: (2022)

Periprocedural Hydrogen Sulfide Therapy Improves Vascular Remodeling and Attenuates Vein Graft Disease
por: Kip, Peter, et al.
Publicado: (2020)

A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery
por: Cheng, Yujing, et al.
Publicado: (2021)

Graft preservation confers myocardial protection during coronary artery bypass grafting
por: Szalkiewicz, Philipp, et al.
Publicado: (2022)

Full Calcified Jacket of Saphenous Vein Graft
por: Kim, Hyun Soo, et al.
Publicado: (2013)

Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response
por: Wezel, Anouk, et al.
Publicado: (2016)

Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study
por: Gao, Jing, et al.
Publicado: (2018)

Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies
por: Pluijmert, Niek J., et al.
Publicado: (2021)

Patency and adverse outcomes of sequential vs. individual saphenous vein grafts in coronary artery bypass: A meta-analysis
por: Jiao, He, et al.
Publicado: (2022)

Antithrombotic therapy in patients receiving saphenous vein coronary artery bypass grafts: a protocol for a systematic review and network meta-analysis
por: Solo, Karla, et al.
Publicado: (2018)

The Etiology and Molecular Mechanism Underlying Smooth Muscle Phenotype Switching in Intimal Hyperplasia of Vein Graft and the Regulatory Role of microRNAs
por: Zhang, Dengshen, et al.
Publicado: (2022)

Myostatin Inhibits Vascular Smooth Muscle Cell Proliferation and Local 14q32 microRNA Expression, But Not Systemic Inflammation or Restenosis
por: Goossens, Eveline A.C., et al.
Publicado: (2020)

Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review
por: Janssen, Eva, et al.
Publicado: (2021)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Short-term outcomes of drug-coated balloon versus drug-eluting stent for de novo saphenous vein graft lesions in coronary heart disease
por: Lin, Li, et al.
Publicado: (2023)

Cold-Inducible RNA-Binding Protein but Not Its Antisense lncRNA Is a Direct Negative Regulator of Angiogenesis In Vitro and In Vivo via Regulation of the 14q32 angiomiRs—microRNA-329-3p and microRNA-495-3p
por: Goossens, Eveline A. C., et al.
Publicado: (2021)

Performance of a HeartLogic(TM) Based Care Path in the Management of a Real-World Chronic Heart Failure Population
por: Feijen, Michelle, et al.
Publicado: (2022)

Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices
por: Kortekaas, Kirsten A., et al.
Publicado: (2022)

Upper Extremity Deep Vein Thrombosis and Asymptomatic Vein Occlusion in Patients With Transvenous Leads: A Systematic Review and Meta-Analysis
por: Duijzer, Daniël, et al.
Publicado: (2021)

Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization
por: Baganha, Fabiana, et al.
Publicado: (2021)

Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation
por: Zwimpfer, Leon, et al.
Publicado: (2022)

The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model
por: Pouwer, Marianne G., et al.
Publicado: (2018)

The association between iliac vein compression degree and characteristics of first diagnosed left lower extremity deep vein thrombosis
por: Shi, Yadong, et al.
Publicado: (2022)

Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIbα—VWF interaction
por: Baksamawi, Hosam Alden, et al.
Publicado: (2023)

The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease
por: Neijenhuis, Ralph M. L., et al.
Publicado: (2023)

High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine
por: Reijnders, E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i2ggg8bv5ihki8odls506n19rb